Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 14 Pain 13 Pain, Postoperative 12 Cancer Pain 10 Agnosia 7 Chronic Pain 6 Colorectal Neoplasms 4 Colonic Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Mucositis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Supratentorial Neoplasms 2 Pancreatic Neoplasms 2 Pain, Intractable 2 Neoplastic Cells, Circulating 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Inflammation 2 Ileus 2 Hematologic Neoplasms 2 Wounds and Injuries 1 Waldenstrom Macroglobulinemia 1 Vesico-Ureteral Reflux 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1

Interventions

Morphine 1 Levobupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sigmoidal Tumour × Morphine × Clear all

NCT01825993 2013-04-08

2013/004

Corporacion Parc Tauli

Phase 3 Unknown

Sigmoidal Tumour

Data powered by HemOnc (CC BY 4.0) Colophon ⚡